Science Explorer Back to mapMap
Discussion
Company · Calgary · Canada

Resverlogix (Canada)

resverlogix.comROR OpenAlex
Research works
73
▼ 57% vs 2018-21
Citations
1.1k
14.9 per fractional work
Top-10% rate
4.3%
all institutions 10.0%
Open access
41%
world 40%
International
36%
world 18%
Resverlogix (Canada)

Not ranked overall: Resverlogix (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Resverlogix (Canada) work in?

In all years, 46% of research at Resverlogix (Canada) is in Life Sciences, 39% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (39%), Medicine (38%), Social Sciences (5%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 33 fractional works · 45.8% of its workBiochemistry, Genetics and Molecular Biology: 29 fractional works · 39.2% of its workMolecular Biology: 27 fractional works · 36.5% of its workCancer Research: 1 fractional works · 1.1% of its workBiochemistry: 1 fractional works · 0.9% of its workGenetics: 0 fractional works · 0.7% of its workImmunology and Microbiology: 3 fractional works · 3.6% of its workImmunology: 2 fractional works · 2.2% of its workVirology: 1 fractional works · 1.4% of its workAgricultural and Biological Sciences: 1 fractional works · 1.6% of its workAnimal Science and Zoology: 1 fractional works · 1.1% of its workPlant Science: 0 fractional works · 0.5% of its workNeuroscience: 1 fractional works · 0.7% of its workBiological Psychiatry: 0 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.6% of its workToxicology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Sciences: 28 fractional works · 38.9% of its workMedicine: 28 fractional works · 37.9% of its workPhysiology: 4 fractional works · 5.2% of its workCardiology and Cardiovascular Medicine: 4 fractional works · 5.1% of its workEndocrinology, Diabetes and Metabolism: 3 fractional works · 4.4% of its workHematology: 3 fractional works · 3.8% of its workSurgery: 3 fractional works · 3.5% of its workInfectious Diseases: 2 fractional works · 3.0% of its workOncology: 2 fractional works · 2.3% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.0% of its workPharmacology: 1 fractional works · 1.8% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.3% of its workNephrology: 1 fractional works · 1.3% of its workNeurology: 1 fractional works · 0.8% of its workEpidemiology: 1 fractional works · 0.7% of its workPsychiatry and Mental health: 0 fractional works · 0.5% of its workUrology: 0 fractional works · 0.5% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.2% of its workGeriatrics and Gerontology: 0 fractional works · 0.2% of its workOphthalmology: 0 fractional works · 0.2% of its workTransplantation: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.5% of its workHealth Professions: 1 fractional works · 0.8% of its workSpeech and Hearing: 0 fractional works · 0.5% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.2% of its workEquine: 0 fractional works · 0.2% of its workPhysical Sciences: 7 fractional works · 9.9% of its workEngineering: 3 fractional works · 4.3% of its workAerospace Engineering: 1 fractional works · 1.5% of its workElectrical and Electronic Engineering: 1 fractional works · 1.1% of its workComputational Mechanics: 1 fractional works · 0.8% of its workMechanical Engineering: 0 fractional works · 0.5% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 2 fractional works · 2.8% of its workArtificial Intelligence: 1 fractional works · 1.1% of its workSignal Processing: 0 fractional works · 0.7% of its workComputer Networks and Communications: 0 fractional works · 0.5% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 1 fractional works · 1.5% of its workOrganic Chemistry: 1 fractional works · 1.5% of its workChemical Engineering: 0 fractional works · 0.5% of its workProcess Chemistry and Technology: 0 fractional works · 0.5% of its workEnvironmental Science: 0 fractional works · 0.5% of its workEnvironmental Engineering: 0 fractional works · 0.5% of its workMathematics: 0 fractional works · 0.3% of its workStatistics and Probability: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.1% of its workSocial Sciences: 4 fractional works · 5.4% of its workSocial Sciences: 4 fractional works · 4.8% of its workSociology and Political Science: 2 fractional works · 2.7% of its workTransportation: 1 fractional works · 1.4% of its workGender Studies: 0 fractional works · 0.7% of its workPsychology: 0 fractional works · 0.6% of its workClinical Psychology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.1% of its workALL ITS WORKResverlogix(Canada)73fractional works, all years
Life Sciences46%Physical Sciences10%Health Sciences39%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 18 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2939.2%
    2. Immunology and Microbiology33.6%
    3. Agricultural and Biological Sciences11.6%
    4. Neuroscience10.7%
    5. Pharmacology, Toxicology and Pharmaceutics00.6%
    1. Medicine2837.9%
    2. Health Professions10.8%
    3. Veterinary00.2%
    1. Engineering34.3%
    2. Computer Science22.8%
    3. Chemistry11.5%
    4. Chemical Engineering00.5%
    5. Environmental Science00.5%
    6. Mathematics00.3%
    7. Physics and Astronomy00.1%
    1. Social Sciences44.8%
    2. Psychology00.6%
    3. Economics, Econometrics and Finance00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.88× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.87× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 3.38× its world share, 0 worksImmunology and Micro…Chemical Engineering: 7.30× its world share, 0 worksChemical EngineeringChemistry: 0.95× its world share, 0 worksChemistryComputer Science: 0.07× its world share, 0 worksComputer ScienceEngineering: 0.09× its world share, 0 worksEngineeringMathematics: 1.09× its world share, 0 worksMathematicsMedicine: 2.49× its world share, 6 worksMedicineVeterinary: 9.40× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 9.4×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Veterinary9.40×0 works
  2. Chemical Engineering7.30×0 works
  3. Biochemistry, Genetics and Molecular Biology5.87×4 works
  4. Immunology and Microbiology3.38×0 works
  5. Medicine2.49×6 works
  6. Agricultural and Biological Sciences1.88×1 works
  7. Mathematics1.09×0 works
  8. Chemistry0.95×0 works
  9. Engineering0.09×0 works
  10. Computer Science0.07×0 works

Who are the top researchers at Resverlogix (Canada)?

Ranked on the quality score, Jan O. Johansson, Ravi Jahagirdar and Li Fu lead among researchers whose main affiliation is Resverlogix (Canada).

  1. 1 Jan O. Johansson Canada · #760,331 worldwide 2.1k citations · 102 works
  2. 2 Ravi Jahagirdar Canada · #1,191,648 worldwide 929 citations · 40 works
  3. 3 Li Fu Canada · #1,296,491 worldwide 1.3k citations · 73 works
  4. 4 Sylwia Wasiak Canada · #1,372,526 worldwide 5.2k citations · 82 works
  5. 5 Ewelina Kulikowski Canada · #1,429,466 worldwide 1.9k citations · 110 works
  6. 6 Christopher Halliday Canada · #1,559,322 worldwide 996 citations · 53 works
  7. 7 Michael Sweeney Canada · #1,573,104 worldwide 1.5k citations · 69 works
  8. 8 Henrik Claus Hansen Canada · #1,720,676 worldwide 1.5k citations · 57 works
  9. 9 Gregory S. Wagner Canada · #1,728,786 worldwide 971 citations · 25 works
  10. 10 Cyrus Calosing Canada · #1,963,727 worldwide 963 citations · 36 works
All ranked researchers at Resverlogix (Canada)

What are the most cited papers from Resverlogix (Canada)?

The most cited paper from Resverlogix (Canada) is "BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection" (Richard J. Mills et al., 2021), with 240 citations. Next come "RVX-208" (233) and "RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist" (201).

Most cited papers
#PaperReleasedCitations
1 BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection Richard J. Mills et al. · Cell Open access 18 Mar 2021 240
2 RVX-208 Dana Bailey, Ravi Jahagirdar, ALLAN S. GORDON et al. · Journal of the American College of Cardiology Open access Jun 2010 233
3 RVX-208, an Inducer of ApoA-I in Humans, Is a BET Bromodomain Antagonist Kevin G. McLure, Emily M. Gesner, Laura M. Tsujikawa et al. · PLoS ONE Open access 31 Dec 2013 201
4 Efficacy and Safety of a Novel Oral Inducer of Apolipoprotein A-I Synthesis in Statin-Treated Patients With Stable Coronary Artery Disease Stephen James Nicholls, ALLAN S. GORDON, Jan Erik Johansson et al. · Journal of the American College of Cardiology Open access 24 Jan 2011 174
5 Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes Kausik Kumar Ray, Stephen James Nicholls, Kevin A. Buhr et al. · JAMA Open access 27 Mar 2020 172
All 65 most cited papers, with filters and sorting

Which keywords describe research at Resverlogix (Canada)?

By fractional works in all years, weighted toward what it does more of than the world: Transcriptional Regulation, BET Bromodomains, PROTACs, Cancer Therapy, Obesity, Metabolic Syndrome, Cardiovascular Disease and Inflammation.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Transcriptional Regulation20▲ 109×3 topics
  2. BET Bromodomains19▲ 1290×1 topic
  3. PROTACs19▲ 1290×1 topic
  4. Cancer Therapy7▲ 15×5 topics
  5. Inflammation6▲ 3.4×12 topics
  6. Cardiovascular Disease5▲ 6.2×11 topics
  7. Obesity5▲ 8.6×6 topics
  8. Metabolic Syndrome5▲ 7.5×6 topics
  9. Atherosclerosis4▲ 15×6 topics
  10. Heart Failure4▲ 11×4 topics
  11. Epigenetic Regulation3▲ 21×3 topics
  12. Insulin Resistance3▲ 9.8×5 topics
  13. Cancer3▲ 2.9×11 topics
  14. Proteasome Inhibitors3▲ 57×2 topics
  15. Weight Loss3▲ 25×2 topics
  16. Gene Expression3▲ 6.2×2 topics
  17. HDAC Inhibitors3▲ 189×1 topic
  18. Histone Deacetylases3▲ 189×1 topic
  19. Vaccine2▲ 8.5×2 topics
  20. Alzheimer's Disease2▲ 11×3 topics
  21. Diagnosis Criteria2▲ 98×1 topic
  22. Immune Response2▲ 4.9×7 topics
  23. International Myeloma Working Group2▲ 98×1 topic
  24. Cholesterol2▲ 16×3 topics
  25. Ketogenic Diet2▲ 27×1 topic
  26. Low-Carbohydrate Diet2▲ 32×1 topic
  27. Metabolism2▲ 4.1×7 topics
  28. ACE2 Receptor2▲ 22×2 topics
  29. SARS-CoV-22▲ 17×2 topics
  30. Clinical Guidelines2▲ 7.3×3 topics
  31. Glucose Metabolism2▲ 23×2 topics
  32. Immunity2▲ 7.0×3 topics
  33. Renal Function2▲ 20×2 topics
  34. Tumor Microenvironment2▲ 6.2×4 topics
  35. Coronary Artery Disease2▲ 17×2 topics
  36. Coronavirus2▲ 18×1 topic
  37. Hypertension2▲ 5.9×4 topics
  38. Mutation2▲ 14×2 topics
  39. spike protein2▲ 47×1 topic
  40. Endothelial Function1▲ 24×2 topics

Which research topics does Resverlogix (Canada) publish most on?

By volume in 2022-now: Protein Degradation and Inhibitors, Heart Failure Treatment and Management, Chromatin Remodeling and Cancer and Peptidase Inhibition and Analysis.

Protein Degradation and …2Protein Degradation and Inhibitors: 2 fractional worksHeart Failure Treatment …1Heart Failure Treatment and Management: 1 fractional worksChromatin Remodeling and…1Chromatin Remodeling and Cancer: 1 fractional worksPeptidase Inhibition and Analysis: 1 fractional worksAnimal Nutrition and Physiology: 1 fractional worksDiet, Metabolism, and Di…1Diet, Metabolism, and Disease: 1 fractional worksRenal and Vascular Pathologies: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional worksPlant responses to elevated CO2: 0 fractional works
Molecular BiologyCardiology and Cardiovascular MedicineOncologyAnimal Science and Zoology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Degradation and Inhibitors Molecular Biology 2 works
  2. 2 Heart Failure Treatment and Management Cardiology and Cardiovascular Medicine 1 works
  3. 3 Chromatin Remodeling and Cancer Molecular Biology 1 works
  4. 4 Peptidase Inhibition and Analysis Oncology 1 works
  5. 5 Animal Nutrition and Physiology Animal Science and Zoology 1 works
  6. 6 Diet, Metabolism, and Disease Endocrinology, Diabetes and Metabolism 1 works
  7. 7 Renal and Vascular Pathologies Pulmonary and Respiratory Medicine 0 works
  8. 8 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  9. 9 Ubiquitin and proteasome pathways Molecular Biology 0 works
  10. 10 Plant responses to elevated CO2 Plant Science 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available40.9%not open59.1%

World: 40% of research is openly available.

with international co-authors36.4%domestic only63.6%

World: 18% is written across borders.

How has Resverlogix (Canada)'s research output changed?

Output in 2022-2025 was 57% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Resverlogix (Canada) as a percentage of every work published that year, 0.000023% in 2024.

still counting0.00010%0.00020%0.00030%Resverlogix (Canada)0.0000065% in 20251990200020102020

Fractional works of Resverlogix (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Calgary

All research institutions in Calgary

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Resverlogix (Canada). Posts are plain text and can be reported.